SYM Financial’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$216K Buy
+2,055
New +$191K 0.02% 382
2026
Q1
– Sell
-2,658
Closed -$213K – 439
2025
Q4
$213K Buy
+2,658
New +$179K 0.02% 305

Other funds holding HAE

SYM Financial's HAE Position: Q3 2026 in Review

SYM Financial opened a new position in Haemonetics (HAE) in Q3 2026: 2,055 shares worth $216K. The stake represents 0.02% of the portfolio and ranks #382 among its holdings. This is a return to the name: SYM Financial previously reported a position in HAE as recently as Q4 2025.

SYM Financial first reported a position in HAE in Q4 2025 and has held it in 2 quarters since. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • SYM Financial held 2,055 shares of Haemonetics worth $216K as of Q3 2026.
  • Haemonetics was a new SYM Financial position in Q3 2026.
  • Haemonetics made up 0.02% of SYM Financial's portfolio in Q3 2026, its #382 holding.
  • SYM Financial first reported a position in Haemonetics in Q4 2025 and has held it in 2 quarters since.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on SYM Financial's 13F filing for Q3 2026, filed 26 Oct 2026.